Pharma’s existing model may be a liability in the race to develop drugs and vaccines to combat COVID-19.
Markus Scholz and N. Craig Smith
The business climate remains unpredictable, but supply chain leaders should plot their comebacks.
What managers can learn from the coronavirus outbreak.
Howard Yu and Mark J. Greeven
The kinds of challenges we face with the coronavirus point to permanent changes we must make.
New research offers companies a framework for managing successful country portfolios.
Stephen A. Wilson and Megan Beck
How cities deal with AI-related changes will determine which ones will thrive in the future.
Timocin Pervane and Kaijia Gu
Developing-world entrepreneurs need to build networks that compensate for weak public institutions.
Tarun Khanna, interviewed by Frieda Klotz
Will Chinese technology companies gain a first-mover advantage in the race for 5G?